Table 2 Detailed characteristics and outcome of the 11 LCH patients included in the study
Patient N° | Disease type (SS-m vs MS) | Response after MACOP-B | Relapse/Progression | DFS/PFS | Status |
|---|---|---|---|---|---|
1 | SS-m | CR | No | 144+ | Alive (CR) |
2 | MS | PR | Yes | 8 | Dead (PD) |
3 | SS-m | CR | Yes | 62 | Dead (PD) |
4 | MS | CR | No | 228+ | Alive (CR) |
5 | SS-m | CR | No | 216+ | Alive (CR) |
6 | MS | PR | Yes | 5 | Alive (II CR, +66 m after ASCT) |
7 | SS-m | CR | No | 96+ | Alive (CR) |
8 | MS | CR | No | 47+ | Alive (CR) |
9 | MS | CR | No | 32+ | Alive (CR) |
10 | SS-m | CR | No | 24+ | Alive (CR) |
11 | SS-m | PR | Yes | 6 | Alive (PD, ASCT ongoing) |